This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Vyvanse (2015-12-23)
- Starting date:
- December 23, 2015
- Posting date:
- December 31, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-56514
Affected Products
Vyvanse
Reason
Some labels were found missing on product bottles from these lots.
Depth of distribution
Wholesalers across Canada
Affected products
Vyvanse
DIN, NPN, DIN-HIM
DIN 02322951
Dosage form
Capsule
Strength
Lisdexamfetamine Dimesylate 30mg
Lot or serial number
- AD8671B
- AD8672B
Companies
- Recalling Firm
-
Shire Pharma Canada ULC
2250 Alfred-Nobel Blvd, suite 500
Saint-Laurent
H4S 2C9
Quebec
CANADA
- Marketing Authorization Holder
-
Shire Pharma Canada ULC
2250 Alfred-Nobel Blvd, suite 500
Saint-Laurent
H4S 2C9
Quebec
CANADA